These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases. Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472 [TBL] [Abstract][Full Text] [Related]
5. FADD gene pathogenic variants causing recurrent febrile infection-related epilepsy syndrome: Case report and literature review. Giovannini G; Giannoccaro MP; Cioclu MC; Orlandi N; Liguori R; Meletti S Epilepsia; 2024 Jul; 65(7):e119-e124. PubMed ID: 38752438 [TBL] [Abstract][Full Text] [Related]
6. The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): A literature review. Culleton S; Talenti G; Kaliakatsos M; Pujar S; D'Arco F Epilepsia; 2019 Apr; 60(4):585-592. PubMed ID: 30854647 [TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Pediatric FIRES With Anakinra. Yang JH; Nataraj S; Sattar S Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629 [No Abstract] [Full Text] [Related]
8. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome. Carson R; Stredny CM Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651 [TBL] [Abstract][Full Text] [Related]
9. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus. Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843 [TBL] [Abstract][Full Text] [Related]
10. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents. Hon KL; Leung AKC; Torres AR Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347 [TBL] [Abstract][Full Text] [Related]
13. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases. Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084 [TBL] [Abstract][Full Text] [Related]
15. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535 [TBL] [Abstract][Full Text] [Related]
16. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Specchio N; Pietrafusa N Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459 [TBL] [Abstract][Full Text] [Related]
18. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort). Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T; Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885 [TBL] [Abstract][Full Text] [Related]
19. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable? Nausch E; Schaffeldt L; Tautorat I; Margraf NG; Häusler M; Kluger G; Kellinghaus C; Borzikowsky C; Laufs H; van Baalen A Seizure; 2022 Mar; 96():18-21. PubMed ID: 35042004 [TBL] [Abstract][Full Text] [Related]
20. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult. Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]